A primary risk factor of cardiovascular disease is referred to the high concentration of plasma cholesterol. The alleviation of plasma cholesterol and inhibition of the catalytic domain of human 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), provides an alternative therapeutic candidate for reducing cholesterol. The present study evaluates the impact of rice bran protein hydrolysate (RBPH) on cholesterol homeostasis. The RBPH was produced by in vitro digestion of the extracted protein using commercial pepsin and pancreatic enzymes under optimized conditions. The hydrolysate was subjected to RP-HPLC and LC–MS profiling indicating three major peaks having masses ranging from 120 to 903 m/z. The degree of hydrolysis for producing the bioactive peptides has been marked with 61.53 ± 0.36%. SDS-PAGE reveals resistance to digestion compared to the native protein extracted from rice bran. The RBPH regulates the cholesterol level in two ways, the first potential role is by restricting the recycling of bile salts to the liver via direct excretion, second by exhibiting maximum micellar cholesterol inhibitory capacity and HMGCR inhibition in a dose dependent manner. The modulatory effect of RBPH on cholesterol homeostasis suggests hypocholesterolaemic property which could find an excellent application in developing physiological functional foods. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Peptide Research & Therapeutics is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
